mHealth: A Utilization Review by Feature Classification for Sustained Use

mHealth is a fast growing segment for healthcare. However, there has been little research into the specific elements of mHealth that can drive continued use for optimization of the potential benefits. The purpose of this case study was to use the Delone and McLean Information System Model as a framework for classification of mHealth functionality and then to review the utilization of those categories over a six month period of time. A sample of 137 pediatric diabetics was reviewed. The activation rate was high at 94.9% indicating an interest in using mHealth. There was higher utilization of system features in the group of users with 60.3% of total uses being related to a system feature. There also were specific use patterns between gender with male patients consisting of 66.2% of the overall uses. Future applications should focus on system features and customization by gender to support sustained use

The safe administration of medication within the electromagnetic scenarios of the Internet of Things (IoT): looking towards the future

This paper has focused on analyzing the impact of Information and Communication Technologies (ICTs) to prevent or reduce errors during therapeutic drug administration. The methodology used has included scientific literature and marketed appliances reviews and laboratory tests on radiant devices. The role of the patient has been analyzed, both in terms of compliance with the prescribed treatments and user of technical solutions designed for administering medication. In addition, it has taken into account, how a future characterized by multiple technologies designed to support our daily routines, including health care, might affect the current model of relationship between health professionals and patients. Particular attention has been given to safety risks of ICTs in environments characterized by concurrent electromagnetic emissions operating at different frequencies. Implications and new scenarios from Internet of Things or IoT, have been considered, in light of the approach taken jointly by the European Commission and the European Technology Platform on Intelligent Systems Integration – EPoSS, in their 2008 report Internet of Things in 2020: a roadmap for the future, and how the concept has evolved since then.Chapter 1. Adverse drug events. Chapter 2. ICTs in everyday life and healthcare. Chapter 3. the challenge of electromagnetic safety. Chapter 4. ICTs in health care and in the prevention of medication errors: IoT. Chapter 5. A more effective and safer alternative approach. Chapter 6. Technological proposal 7. Conclusions.N

The Role of Mobile Health Technologies in Allergy Care:an EAACI Position Paper

Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health-related services, data and information flow, patient self-management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the "Be He@lthy, Be Mobile" WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the "General Data Protection Regulation" and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician- to patient-centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed

ASSESSING THE EFFECTIVENESS OF MEDICAL/DRUG-RELATED APPS IN PATIENT HEALTHCARE MANAGEMENT

Abstract In recent years, the availability and usage of medical and drug-related mobile applications (apps) have rapidly increased, promising to revolutionize patient healthcare management. This research paper aims to evaluate the effectiveness of medical/drug-related apps in enhancing patient outcomes and healthcare management. The study will employ a mixed-methods approach, starting with a comprehensive review of existing literature on medical/drug-related apps, their functionalities, and their impact on patient care. A systematic analysis of various app categories, including medication management, symptom trackers, appointment reminders, and health education, will be conducted. Quantitative data will be collected through surveys and usage analytics to assess the adoption rates, user satisfaction, and perceived effectiveness of medical/drug-related apps among patients. Additionally, qualitative data will be gathered through interviews or focus groups to explore users' experiences, challenges, and perceptions related to these apps. Key performance indicators such as medication adherence, self-care behaviors, patient empowerment, and health outcomes will be assessed to determine the impact of medical/drug-related apps on patient healthcare management. Statistical analysis and thematic coding techniques will be applied to analyze the data and identify patterns and themes. The research will also investigate the factors influencing app adoption and the barriers or challenges faced by patients in utilizing these apps effectively. Privacy and security concerns, user interface design, and healthcare professional recommendations will be considered in the evaluation process

Optimizing the Collection and Use of Patient-Generated Health Data

This dissertation aims to examine the collection and use of digital patient-generated health data (PGHD) in real-world settings, including existing barriers from the perspectives of patients and healthcare providers, and possible approaches to optimizing the process. In Chapter One, the potential of PGHD to improve health and wellness, particularly for individuals with chronic conditions, as well as known barriers to PGHD collection and use, are described. One chronic condition in particular, atrial fibrillation (AF), is then introduced as a use case for PGHD. Chapter Two contains an integrative review synthesizing findings from eleven studies reporting patients’ and providers’ needs when collecting and using PGHD, and identifying convergence and divergence between needs. Chapter Three contains a quantitative evaluation of sustained engagement, currently a major barrier to collection of PGHD, in a group of adults self-monitoring AF, as well as predictors and moderators of engagement that come from an adapted version of the Unified Theory of Acceptance and Use of Technology (UTAUT). These individuals were previously enrolled in the randomized, controlled trial, the iPhone® Helping Evaluate Atrial Fibrillation Rhythm through Technology (iHEART). In Chapter Four, the adapted UTAUT model is explored in more detail through a qualitative investigation of sustained engagement with patients, healthcare providers, and research coordinators involved in the iHEART trial. Chapter Five summarizes the findings of this dissertation, including strengths and limitations, and elicits implications for the intersection of health policy and clinical practice, design, nursing, and future research from the findings

Overcoming the Digital Divide for Older Patients With Respiratory Disease: Focus Group Study

Background: The need for and adoption of eHealth programs are growing worldwide. However, access can be limited among patients with low socioeconomic backgrounds, often resulting in a so-called “digital divide” due to a mismatch between eHealth and target populations that can gain benefit. This digital divide can result in unsuccessful eHealth implementations, which is of critical importance to health care.Objective: This study evaluated the opinions of elderly patients with asthma and chronic obstructive pulmonary disease (COPD) about an existing pharmacy-based personalized patient web portal that provides medication overview and information on associated diagnoses. The aim was to obtain insights on the common barriers of elderly people when using health-related websites, which can help to improve accessibility.Methods: This was a cross-sectional qualitative study of a patient panel of the Groningen Research Institute for Asthma and COPD in primary care. Participants were required to be older than 55 years, be Dutch speaking, have no prior experience with the study website, and be diagnosed with a chronic respiratory illness. Two focus groups were created, and they completed a 45-minute session for testing the website and a 120-minute session for semistructured interviews. The focus group sessions were recorded, transcribed verbatim, and analyzed by content analysis.Results: We enrolled 11 patients (9 women) with a mean age of 66 (SD 9) years. Of these, 5 had asthma, 3 had COPD, 2 had asthma-COPD overlap syndrome, and 1 had bronchiectasis. Participants were generally positive about the website, especially the areas providing disease-related information and the medication overview. They appreciated that the website would enable them to share this information with other health care providers. However, some difficulties were reported with navigation, such as opening a new tab, and others reported that the layout of the website was difficult either because of visual impairments or problems with navigation. It was also felt that monitoring would only be relevant if it is also checked by health care professionals as part of a treatment plan. Participants mentioned few privacy or safety concerns.Conclusions: It is feasible to develop websites for elderly patients; however, developers must take the specific needs and limitations of elderly people into account (eg, navigation problems, poor vision, or poor hand-eye coordination). The provision of information appears to be the most important aspect of the website, and as such, we should endeavor to ensure that the layout and navigation remain basic and accessible. Patients are only motivated to use self-management applications if they are an integrated part of their treatment. The usability of the website can be improved by including older people during development and by implementing design features that can improve accessibility in this group